[Exantia® tissue bulking agent for the treatment of fecal incontinence]
Oubiña M, Pichon-Riviere A, García Martí S, Augustovski F, Alcaraz A, Bardach A, Ciapponi A, Glujovsky D, López A, Meza V
Record ID 32015000861
Spanish
Authors' recommendations:
The evidence found about this technique is scarce and of very low methodological quality.
In general, some perianal injectable bulking agents were able to show certain effectiveness in randomized clinical trials against placebo: they included patients with fecal incontinence (FI) due to internal anal sphincter disruption or weakness, decreasing the FI episodes for a period ranging from six months to two years. However, all these studies used perianal injectable bulking agents other than Exantia®.
Several health insurance companies consider there is not enough evidence to cover this type of treatment because the follow-up period of these studies is short.
Exantia® is a perianal injectable bulking agent which could have similar effectiveness to other agents, nevertheless, its effectiveness has not been demonstrated in studies of high methodological quality yet.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Acrylic Resins
- Biocompatible Materials
- Polymers
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.